Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Jul 31;13(7):1315-1318.
doi: 10.21037/tau-24-20. Epub 2024 Jul 4.

Combination of PARP and DNA methylation inhibitors as a potential personalized therapy for SETD2-mutated clear-cell renal cancers

Ali Shahini  1   2 , Yasser Riazalhosseini  1   2
Affiliations
Editorial

Combination of PARP and DNA methylation inhibitors as a potential personalized therapy for SETD2-mutated clear-cell renal cancers

Ali Shahini et al. Transl Androl Urol. .
No abstract available

Keywords: DNA methylation; PARP inhibitors (PARPi); SETD2 mutation; renal cell carcinoma.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://tau.amegroups.com/article/view/10.21037/tau-24-20/coif). The authors have no conflicts of interest to declare.

Comment on

References

    1. Ljungberg B, Albiges L, Abu-Ghanem Y, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur Urol 2022;82:399-410. 10.1016/j.eururo.2022.03.006 - DOI - PubMed
    1. Gossage L, Eisen T, Maher ER. VHL, the story of a tumour suppressor gene. Nat Rev Cancer 2015;15:55-64. 10.1038/nrc3844 - DOI - PubMed
    1. Schiavoni V, Campagna R, Pozzi V, et al. Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies. Cancers (Basel) 2023;15:3207. 10.3390/cancers15123207 - DOI - PMC - PubMed
    1. Yang J, Wang K, Yang Z. Treatment strategies for clear cell renal cell carcinoma: Past, present and future. Front Oncol 2023;13:1133832. 10.3389/fonc.2023.1133832 - DOI - PMC - PubMed
    1. McKay RR, Bossé D, Choueiri TK. Evolving Systemic Treatment Landscape for Patients With Advanced Renal Cell Carcinoma. J Clin Oncol 2018. [Epub ahead of print]. doi: .10.1200/JCO.2018.79.0253 - DOI - PubMed

LinkOut - more resources